Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Peripheral Nervous System Diseases 3Lymphoma 3Lymphoma, Large B-Cell, Diffuse 2Breast Neoplasms 2Wilms Tumor 1Vaso-Occlusive Crises 1Sarcoma 1Prostatic Neoplasms 1Pain 1Neurotoxicity Syndromes 1Neuroectodermal Tumors, Primitive, Peripheral 1Multiple Myeloma 1Multiple Endocrine Neoplasia Type 1 1Mucositis 1Lymphoma, Non-Hodgkin 1Lymphoma, Extranodal NK-T-Cell 1Leukemia 1Kidney Neoplasms 1Esophagitis 1Dendritic Cell Sarcoma, Interdigitating 1Burkitt Lymphoma 1Anemia, Sickle Cell 1

Interventions

nabiximols 7Morphine 7Fentanyl 7Hydromorphone 6Tapentadol 5Radiotherapy 4Prednisone 3Methadone 3Ketamine 3Duloxetine Hydrochloride 3Calcium Dobesilate 3Calcium 3Analgesia 3Acetaminophen 3cabozantinib 2Zoledronic Acid 2Surveys and Questionnaires 2Sugars 2Radiosurgery 2Pregabalin 2Pain Management 2Oxycodone 2Minocycline 2Letrozole 2Ibuprofen 2Diclofenac 2Dexamethasone 2Cryosurgery 2Calcium Gluconate 2Bupivacaine 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Pain × Glutamine × Clear all
NCT00217724 2017-05-09

Glutamine in Preventing Myalgia and/or Arthralgia in Patients Who Are Receiving Paclitaxel For Cancer

OHSU Knight Cancer Institute

Phase NA Terminated
18 enrolled 7 charts

Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡